{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:21:49Z","timestamp":1782598909063,"version":"3.54.5"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:p>Persistent facial erythema and flushing in rosacea remain challenging to treat with current therapies. A recent noteworthy open-label trial found that erenumab, a calcitonin gene-related peptide receptor inhibitor, significantly reduced moderate to extreme flushing and erythema in patients with treatment-resistant disease, highlighting a novel neurovascular-targeted therapeutic approach.<\/jats:p>","DOI":"10.1093\/ced\/llaf299","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T08:43:26Z","timestamp":1752482606000},"page":"2354-2355","source":"Crossref","is-referenced-by-count":2,"title":["Calcitonin gene-related peptide inhibition: the advent of biologics in rosacea"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7122-3469","authenticated-orcid":false,"given":"Gurnoor","family":"Kaur","sequence":"first","affiliation":[{"name":"School of Medicine and Dentistry, University of Central Lancashire , Preston ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Bhatt","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, University of Central Lancashire , Preston ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4891-8231","authenticated-orcid":false,"given":"Yan Ching","family":"Chow","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, University of Central Lancashire , Preston ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7848-8669","authenticated-orcid":false,"given":"Chawalpat","family":"Siripanich","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, University of Central Lancashire , Preston ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8588-791X","authenticated-orcid":false,"given":"Faisal R","family":"Ali","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, University of Central Lancashire , Preston ,","place":["UK"]},{"name":"Mid Cheshire NHS Foundation Trust , Crewe ,","place":["UK"]},{"name":"St John\u2019s Institute of Dermatology , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"2025102707124831200_llaf299-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2020.0417","article-title":"Rosacea","volume":"82","author":"Searle","year":"2021","journal-title":"Br J Hosp Med"},{"key":"2025102707124831200_llaf299-B2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamadermatol.2024.0408","article-title":"Erenumab for treatment of persistent erythema and flushing in rosacea","volume":"160","author":"Wienholtz","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025102707124831200_llaf299-B3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/0333102417731777","article-title":"The relationship between migraine and rosacea: systematic review and meta-analysis","volume":"38","author":"Christensen","year":"2017","journal-title":"Cephalalgia"},{"key":"2025102707124831200_llaf299-B4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/jdv.19954","article-title":"Elevated plasma levels of calcitonin gene-related peptide in individuals with rosacea: a cross-sectional case\u2013control study","volume":"39","author":"Wienholtz","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025102707124831200_llaf299-B5","doi-asserted-by":"crossref","first-page":"100361","DOI":"10.1016\/j.bbih.2021.100361","article-title":"Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions","volume":"18","author":"Kim","year":"2021","journal-title":"Brain, Behav Immun Health"},{"key":"2025102707124831200_llaf299-B6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/bjd\/ljad277","article-title":"An exploratory comparative case series of calcitonin gene-related peptide monoclonal antibodies in patients with migraine with rosacea","volume":"189","author":"Sia","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf299\/63742193\/llaf299.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/11\/2354\/63742193\/llaf299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/11\/2354\/63742193\/llaf299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:12:56Z","timestamp":1761563576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/11\/2354\/8198682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":6,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,7,14]]},"published-print":{"date-parts":[[2025,10,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf299","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,7,14]]}}}